• Nichi-Iko®
  • Serialization/Track and Trace
  • Investors
  • Careers
  • Anti-Capital Punishment Statement
  • Contact Us
  • Online Ordering Portal
  • sagentbiosimilars.com
  • zoledronicpremix.com
  • glydo.com
Sagent PharmaceuticalsSagent Pharmaceuticals
Sagent Pharmaceuticals
  • Home
  • About
    • Our Executive Team
    • Who We Are
    • What We Do
    • Why We Do It
  • Products
  • PreventIV Measures®
Home > Products > Recent Launches
  • All
  • Alphabetical
  • Therapeutic Category
  • Recent Launches
  • Ready-To-Use
  • Return Goods Policy
  • Search

Recent Launches

  • MICAFUNGIN for Injection
  • LABETALOL Hydrochloride Injection, USP
  • PANTOPRAZOLE Sodium for Injection
  • CIPROFLOXACIN Injection, USP*
  • NEOSTIGMINE Methylsulfate Injection, USP

MICAFUNGIN for Injection

  • 50 mg single-dose vials
  • 100 mg single-dose vials

MICAFUNGIN for Injection

LABETALOL Hydrochloride Injection, USP

  • 100 mg per 20 mL multi-dose vials
  • 200 mg per 40 mL multi-dose vials

LABETALOL Hydrochloride Injection, USP

PANTOPRAZOLE Sodium for Injection

  • 40 mg single-dose vials
  • Sold in a 10 pack and 25 pack

PANTOPRAZOLE Sodium for Injection

CIPROFLOXACIN Injection, USP*

  • 200 mg per 100 mL in 5% Dextrose premix bags
  •  400 mg per 200 mL in 5% Dextrose premix bags

CIPROFLOXACIN Injection, USP*

NEOSTIGMINE Methylsulfate Injection, USP

  • 5 mg per 10 mL multi-dose vials
  • 10 mg per 10 mL multi-dose vials

NEOSTIGMINE Methylsulfate Injection, USP

*Please see full prescribing and safety information, including boxed warning

Product CatalogPRODUCT CATALOG
Diversifying Growth
One of the fastest-growing providers of specialty
www.SagentPharma.com Site Map Privacy Terms of Use for Site(s) Sales Terms & Conditions

The SAGENT logo, SAGENT, SAGENT Pharmaceuticals and PreventIV Measures are registered trademarks of Sagent Pharmaceuticals, Inc.
The Nichi-Iko logo, NICHI-IKO and NIKP are registered trademarks of Nichi-Iko Pharmaceutical Co., Ltd.
© 2023 Sagent Pharmaceuticals, Inc.